BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 17661994)

  • 21. Clinical features of patients with Myasthenia gravis from the Henan province, China.
    Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
    Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.
    Gratton SM; Herro AM; Feuer WJ; Lam BL
    J Neuroophthalmol; 2016 Mar; 36(1):37-40. PubMed ID: 26457691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.
    Deguchi K; Matsuzono K; Nakano Y; Kono S; Sato K; Deguchi S; Tanabe K; Hishikawa N; Ota Y; Yamashita T; Ohta K; Motomura M; Abe K
    Intern Med; 2018 May; 57(10):1455-1458. PubMed ID: 29321424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myasthenia gravis as a cause of head drop in Parkinson disease.
    Uludag IF; Korucuk M; Sener U; Zorlu Y
    Neurologist; 2011 May; 17(3):144-6. PubMed ID: 21532382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bread-and-butter in diagnosis of myasthenia gravis.
    Chan AY; Liu DT
    Arch Neurol; 2005 Dec; 62(12):1939; author reply 1939-40. PubMed ID: 16344357
    [No Abstract]   [Full Text] [Related]  

  • 27. Muscle-specific tyrosine kinase-antibody-positive myasthenic crisis with detailed electrophysiologic studies.
    Yanagawa Y; Hongo Y; Shiozaki H; Kamakura K; Sonoo M; Motomura M
    Am J Emerg Med; 2009 Jul; 27(6):754.e5-6. PubMed ID: 19751644
    [No Abstract]   [Full Text] [Related]  

  • 28. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
    Stickler DE; Stickler LL
    Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Musk-antibody positive myasthenia gravis presenting with isolated neck extensor weakness.
    Casasnovas C; Povedano M; Jaumà S; Montero J; Martínez-Matos JA
    Neuromuscul Disord; 2007 Jul; 17(7):544-6. PubMed ID: 17533129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil in AChR-antibody-positive myasthenia gravis: outcomes in 102 patients.
    Hehir MK; Burns TM; Alpers J; Conaway MR; Sawa M; Sanders DB
    Muscle Nerve; 2010 May; 41(5):593-8. PubMed ID: 20405499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vocal cord paralysis as a manifestation of myasthenia gravis with anti-MuSK antibodies.
    Jiménez Caballero PE; Fermin Marrero JA; Trigo Bragado I; Casado Naranjo I
    Neurologia; 2014 May; 29(4):253-4. PubMed ID: 23040717
    [No Abstract]   [Full Text] [Related]  

  • 33. Experience with patients with anti-MUSK antibody positive myasthenia gravis.
    Sundar U; Shaunbhag P; Lakkas Y; Shrivastava M; Shah A; Vaidya M; Asole D
    J Assoc Physicians India; 2010 Oct; 58():640-2. PubMed ID: 21510119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical aspects of myasthenia explained.
    Verschuuren JJ; Palace J; Gilhus NE
    Autoimmunity; 2010 Aug; 43(5-6):344-52. PubMed ID: 20380587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myasthenia gravis: another autoimmune disease associated with hepatitis C virus infection.
    Eddy S; Wim R; Peter VE; Tanja R; Jan T; Werner VS
    Dig Dis Sci; 1999 Jan; 44(1):186-9. PubMed ID: 9952242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The auto-antigen repertoire in myasthenia gravis.
    Vrolix K; Fraussen J; Molenaar PC; Losen M; Somers V; Stinissen P; De Baets MH; Martínez-Martínez P
    Autoimmunity; 2010 Aug; 43(5-6):380-400. PubMed ID: 20380581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.